Sydney
Australia
The University of Sydney - Melanoma Institute Australia
dedifferentiation, immunotherapy resistance, computational biology, MAPK inhibitor resistance
Melanoma, digital pathology, artificial intelligence
Dysfunctional CD8+ T cells, CD226 (DNAM-1), CD155 (PVR), Cancer immunotherapy, Melanoma, HNSCC, adoptive cell transfer therapy
Merkel cell carcinoma, sentinel node, sentinel node tumor burden, histologic patterns, survival